A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.18
- USD1.21
- USD1.14
- USD4.40
- -17.00%
- --
- 18.08k
- 40M
- 0.85
- -64.50%
Stock News
33 minutes ago
Visa and Mastercard shares slide on stablecoin fears — but is the selloff too harsh?
MarketWatch
35 minutes ago
AMD just showed signs of progress. But can it really take on Nvidia?
MarketWatch
53 minutes ago
From Walmart to car washes, American companies are getting caught up in ICE raids and protests
MarketWatch
53 minutes ago
Americans are losing spending power, say researchers: Most can no longer afford a 'minimal quality of life'
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
